A nanomaterial based on a platform developed by Professor Samuel Stupp crosses the blood-brain barrier and targets harmful ...

UK biotech Engitix has raised a $25 million series A extension from existing investor Netherton Investments, investing on behalf of BlueCrest Capital Management co-founder Mike Platt. The funding will ...

By preserving fat tissue architecture, researchers created organoids that restore insulin function, paving the way for ...

Engitix Announces $25 Million Series A Extension Financing by Existing Investor Mike Platt to Advance ECM-Targeted ...

UK-based biotechnology company Engitix Ltd. has raised a further $25 million from billionaire Michael Platt to help develop its therapies for cancer and fibrosis.

TYBR Health has announced the first US clinical use of the collagen-based tissue protector, B3 GEL System, aimed at ...

Aperture Therapeutics, a biotechnology company pioneering next-generation precision medicines for neurodegenerative diseases, today announced the advancement of its matrix metalloproteinase-9 (MMP9) ...

Tammam Hanna, MD, an orthopedic surgeon in Lubbock, Texas, performed the first U.S. clinical case of TYBR Health’s B3 Gel system, according to a Jan. 5 news release. B3 Gel is a collagen-based tissue ...

Professor Martin James Humphries FMedSci, Professor of Biochemistry at the University of Manchester has been made Officer of ...

A research team reports a promising new strategy: combining two already-approved drugs—silybin, a natural liver-protective compound, and carvedilol, a widely used cardiovascular medicine—to powerfully ...

Senescence. It’s a beautiful-sounding word whose tones suggest it should be a perfume or an essential oil. But that’s not ...

A new study published in the journal Addiction Neuroscience provides evidence that cannabidiol may help prevent the ...